HIGH-THROUGHPUT SCREENING OF GLIOMA STEM CELL LINES FOR DRUG STRUCTURE- AND GENOTYPE-CORRELATED SENSITIVITY TO A PANEL OF TYROSINE KINASE INHIBITORS

John de Groot(University of California, San Francisco), Alfred Yung(The University of Texas MD Anderson Cancer Center), Erik P. Sulman(NYU Langone Health), B. Zuercher(The University of Texas MD Anderson Cancer Center), Camille Thomas(University of Geneva), David H. Drewry(University of North Carolina at Chapel Hill), Clifford Stephan(Texas A&M Health Science Center), Frederick Lang(Houston Medical Center), Roeland Verhaak(Broad Institute), Y. Piao(The University of Texas MD Anderson Cancer Center), Nam Nguyen(University of California, San Diego)
Neuro-Oncology
July 1, 2014
10.1093/neuonc/nou208.36
Cited by 0

Related Papers

Comprehensive molecular characterization of urothelial bladder carcinoma
|Nature|2014|3.1k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Circular ecDNA promotes accessible chromatin and high oncogene expression
|Nature|2019|716
A pan-cancer proteomic perspective on The Cancer Genome Atlas
|Nature Communications|2014|641
TCPA: a resource for cancer functional proteomics data
|Nature Methods|2013|548